Breaking News Instant updates and real-time market news.

CPTA

Capitala Finance

$8.27

0.025 (0.30%)

17:08
11/04/19
11/04
17:08
11/04/19
17:08

Capitala Finance reports Q3 EPS 18c, consensus 24c

Total investment income was $10.1 million for the third quarter of 2019, compared to $11.5 million in the third quarter of 2018. Interest and fee income was $2.2 million lower in third quarter of 2019 as compared to 2018, partially offset by an increase of $1.1 million in dividend income for the comparable periods. Dividend income for the third quarter of 2019 included $0.8 million from Micro Precision, LLC and $0.3 million from Capitala Senior Loan Fund II, LLC. In describing the Company's third quarter activities, Joseph B. Alala, III, Chairman and Chief Executive Officer, stated, "During the third quarter of 2019, we earned a 4.5% return on equity. We anticipate closing several new investments prior to year-end, providing support to net investment income after two quarters of net repayments. Platform liquidity will allow us to remain active investors in the lower middle market. Our investment adviser's recently announced partnership with Mitsui USA is expected to provide the Capitala platform, including Capitala Finance Corp., with additional resources for the growth of our credit and equity strategies focused on investing in small businesses located across North America."

  • 05

    Nov

CPTA Capitala Finance
$8.27

0.025 (0.30%)

08/06/19
LTCO
08/06/19
DOWNGRADE
LTCO
Neutral
Capitala Finance downgraded to Neutral from Buy at Ladenburg
08/06/19
08/06/19
DOWNGRADE

Neutral
Capitala Finance downgraded to Neutral after quarterly results at Ladenburg
As previously reported, Ladenburg analyst Christopher Nolan downgraded Capitala Finance to Neutral from Buy following quarterly results. The analyst notes that the company reported in line Q2 EPS, but NAV/share decreased 18% quarter over quarter driven primarily by a $20M realized loss from its exit from AAE Acquisition, and also impacted by unrealized depreciation.
10/20/19
KBWI
10/20/19
DOWNGRADE
Target $7.5
KBWI
Underperform
Capitala downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Ryan Lynch downgraded Capitala Finance to Underperform from Market Perform with an unchanged price target of $7.50. The stock's valuation is too high given Capitala's track record of below-average and negative historical economic returns, Lynch tells investors in a research note. The company has had "major" credit issues over the past several years, says the analyst, who adds that Capitala's valuation is at a "significant" premium to peers.

TODAY'S FREE FLY STORIES

09:58
12/09/19
12/09
09:58
12/09/19
09:58
Conference/Events
JPMorgan oil services/equip analyst to hold an analyst/industry conference call »

Oil Services &…

PCG

PG&E

$11.30

1.65 (17.10%)

, SIG

Signet Jewelers

$21.05

0.48 (2.33%)

09:55
12/09/19
12/09
09:55
12/09/19
09:55
Options
Early notable gainers among liquid option names on December 9th »

Notable gainers among…

PCG

PG&E

$11.30

1.65 (17.10%)

SIG

Signet Jewelers

$21.05

0.48 (2.33%)

SWKS

Skyworks

$104.20

2.8 (2.76%)

FCX

Freeport McMoRan

$11.97

0.33 (2.84%)

FTV

Fortive

$75.51

2.65 (3.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 07

    Jan

09:55
12/09/19
12/09
09:55
12/09/19
09:55
Conference/Events
JPMorgan homebuilding analyst to hold an analyst/industry conference call »

Homebuilding &…

09:55
12/09/19
12/09
09:55
12/09/19
09:55
Conference/Events
JPMorgan business services analyst to hold analyst/industry conference call »

Business &…

FTSV

Forty Seven

$17.61

3.21 (22.29%)

09:53
12/09/19
12/09
09:53
12/09/19
09:53
Hot Stocks
Breaking Hot Stocks news story on Forty Seven »

Forty Seven trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

TTWO

Take-Two

$119.55

-4.21 (-3.40%)

09:53
12/09/19
12/09
09:53
12/09/19
09:53
Recommendations
Take-Two analyst commentary  »

Take-Two's BioShock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

HY

Hyster-Yale Materials

$60.47

0.66 (1.10%)

09:52
12/09/19
12/09
09:52
12/09/19
09:52
Conference/Events
Hyster-Yale Materials management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 26

    Feb

ZS

Zscaler

$47.38

0.66 (1.41%)

09:50
12/09/19
12/09
09:50
12/09/19
09:50
Options
Funky call sale in ZScaler at market-open »

Funky call sale in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 16

    Dec

RTRX

Retrophin

$13.31

0.05 (0.38%)

09:50
12/09/19
12/09
09:50
12/09/19
09:50
Conference/Events
Retrophin management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ARQL

ArQule

$19.61

9.94 (102.79%)

, LLY

Eli Lilly

$119.52

-0.07 (-0.06%)

09:49
12/09/19
12/09
09:49
12/09/19
09:49
Conference/Events
Wolfe Research biotech analyst to hold an analyst/industry webcast »

Biotech Analyst Tewari…

ARQL

ArQule

$19.61

9.94 (102.79%)

LLY

Eli Lilly

$119.52

-0.07 (-0.06%)

MRK

Merck

$88.76

-0.08 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 11

    Dec

  • 17

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 30

    Jan

  • 05

    Feb

  • 14

    Mar

XFOR

X4 Pharmaceuticals

$10.60

(0.00%)

09:48
12/09/19
12/09
09:48
12/09/19
09:48
Upgrade
X4 Pharmaceuticals rating change  »

X4 Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSV

Forty Seven

$15.86

1.46 (10.14%)

09:48
12/09/19
12/09
09:48
12/09/19
09:48
Hot Stocks
Breaking Hot Stocks news story on Forty Seven »

Forty Seven trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

KOS

Kosmos

$5.41

-0.62 (-10.28%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
Kosmos falls -10.6% »

Kosmos is down -10.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$7.93

-1.42 (-15.19%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -15.2% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPLO

Diplomat Pharmacy

$3.97

-1.855 (-31.87%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
Diplomat Pharmacy falls -31.7% »

Diplomat Pharmacy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPCE

Virgin Galactic

$8.04

0.76 (10.44%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
Virgin Galactic rises 10.4% »

Virgin Galactic is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PCG

PG&E

$11.05

1.4 (14.51%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
PG&E rises 14.7% »

PG&E is up 14.7%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$180.50

24.71 (15.86%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 16.0% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBB

RBB Bancorp

$20.42

(0.00%)

09:45
12/09/19
12/09
09:45
12/09/19
09:45
Conference/Events
RBB Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 12

    Dec

09:45
12/09/19
12/09
09:45
12/09/19
09:45
General news
Treasury 3-year auction outlook: the $38 B sale leads off »

Treasury 3-year auction…

TTWO

Take-Two

$123.76

(0.00%)

09:44
12/09/19
12/09
09:44
12/09/19
09:44
Hot Stocks
Take-Two says newly-formed 'Cloud Chamber' studio developing next BioShock game »

2K, a publishing label of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

ALPN

Alpine Immune Sciences

$3.02

(0.00%)

09:40
12/09/19
12/09
09:40
12/09/19
09:40
Hot Stocks
Alpine Immune Sciences presents ALPN-101 Phase 1 healthy volunteer study data »

Alpine Immune Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$19.03

(0.00%)

, SPCE

Virgin Galactic

$7.28

(0.00%)

09:40
12/09/19
12/09
09:40
12/09/19
09:40
Options
Unusually active option classes on open December 9th »

Unusual total active…

JBLU

JetBlue

$19.03

(0.00%)

SPCE

Virgin Galactic

$7.28

(0.00%)

CHWY

Chewy

$24.93

(0.00%)

VLO

Valero

$93.62

(0.00%)

DELL

Dell Technologies

$47.09

(0.00%)

CRWD

Crowdstrike

$50.89

(0.00%)

ZS

Zscaler

$46.72

(0.00%)

LULU

Lululemon

$229.50

(0.00%)

CGC

Canopy Growth

$18.65

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 12

    Dec

  • 16

    Dec

  • 27

    Feb

  • 09

    Dec

KALV

KalVista

$14.36

0.25 (1.77%)

, MRK

Merck

$88.84

0.09 (0.10%)

09:37
12/09/19
12/09
09:37
12/09/19
09:37
Recommendations
KalVista, Merck analyst commentary  »

Roth says KalVista trial…

KALV

KalVista

$14.36

0.25 (1.77%)

MRK

Merck

$88.84

0.09 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

PSTL

Postal Realty Trust

$15.85

0.15 (0.96%)

09:34
12/09/19
12/09
09:34
12/09/19
09:34
Conference/Events
Postal Realty Trust management to meet with DA Davidson »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.